Skip to main content

Advertisement

Log in

Drug Allergy Delabeling Programs: Recent Strategies and Targeted Populations

  • Published:
Clinical Reviews in Allergy & Immunology Aims and scope Submit manuscript

Abstract

Drug allergy delabeling programs have become an essential element of antibiotic stewardship. Development of delabeling programs involves careful selection of target patient population, thoughtful design of delabeling approach, stakeholder engagement, assembly of key team members, implementation, and evaluation of clinical and safety outcomes. Recent programs have targeted patients thought to be most likely to benefit from removal of inaccurate antibiotic allergy labels, those with β-lactam antibiotic allergies and high-risk populations likely to need β-lactam antibiotics as first-line treatment. This review provides an overview of current risk stratification methods and β-lactam cross-reactivity data and summarizes how different inpatient and outpatient delabeling programs have used these concepts in delabeling algorithms. β-Lactam delabeling programs for inpatients, pediatric patients, and programs utilizing telehealth have been implemented with good outcomes. This review also focuses on delabeling programs for high-risk populations likely to benefit from first-line β-lactam antibiotics. These populations include perioperative, prenatal, and immunocompromised patients. Delabeling programs have been successful in the inpatient and outpatient settings at enabling appropriate antibiotic use. This article reviews delabeling strategies utilized by these programs with a focus on highlighting elements key to their success and future areas for innovation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data Availability

Not applicable.

Code Availability

Not applicable.

Abbreviations

A/I:

Allergy/immunology

AAAAI:

American Academy of Allergy Asthma Immunology

ACOG:

American College of Obstetricians and Gynecologists

ADR:

Adverse drug reaction

ASP:

Antimicrobial stewardship program

β-Lactam:

Beta-lactam

CDC:

Centers for Disease Control and Prevention

C. diff :

Clostridium difficile

CF:

Cystic fibrosis

C-section:

Cesarean section

EHR:

Electronic health record

GBS:

Group B Streptococcus

HIV:

Human immunodeficiency virus

HSCT:

Hematopoietic stem cell transplant

HSR:

Hypersensitivity reaction

ID:

Infectious disease

IDSA:

Infectious Diseases Society of America

IV:

Intravenous

MRSA:

Methicillin-resistant Staphylococcus aureus

PA:

Penicillin allergy

PCN:

Penicillin

PJP:

Pneumocystis jirovecii Pneumonia

PPROM:

Preterm premature rupture of membranes

RA:

Rheumatoid arthritis

SLE:

Systemic lupus erythematosus

SJS/TEN:

Stevens–Johnson syndrome/toxic epidermal necrolysis

ST:

Skin test

UK:

United Kingdom

US:

United States

VRE:

Vancomycin-resistant enterococcus

References 

  1. Joint Commission on Hospital Accreditation (2016) APPROVED: new antimicrobial stewardship standard. Jt Comm Perspect 36(7):1, 3–4, 8

  2. Shenoy ES, Macy E, Rowe T, Blumenthal KG (2019) Evaluation and management of penicillin allergy: a review. JAMA 321(2):188–199

    Article  PubMed  Google Scholar 

  3. Macy E (2014) Penicillin and beta-lactam allergy: epidemiology and diagnosis. Curr Allergy Asthma Rep 14(11):476

    Article  PubMed  CAS  Google Scholar 

  4. Albin S, Agarwal S (2014) Prevalence and characteristics of reported penicillin allergy in an urban outpatient adult population. Allergy Asthma Proc 35(6):489–94

  5. Macy E, Ngor EW (2013) Safely diagnosing clinically significant penicillin allergy using only penicilloyl-poly-lysine, penicillin, and oral amoxicillin. J Allergy Clin Immunol Pract 1(3):258–63

  6. Rimawi RH, Cook PP, Gooch M, Kabchi B, Ashraf MS, Rimawi BH, Gebregziabher M, Siraj DS (2013) The impact of penicillin skin testing on clinical practice and antimicrobial stewardship. J Hosp Med 8(6):341–345

    Article  PubMed  Google Scholar 

  7. Macy E, Contreras R (2014) Health care use and serious infection prevalence associated with penicillin “allergy” in hospitalized patients: a cohort study. J Allergy Clin Immunol 133(3):790–796

    Article  PubMed  Google Scholar 

  8. Blumenthal KG, Lu N, Zhang Y, Li Y, Walensky RP, Choi HK (2018) Risk of meticillin resistant Staphylococcus aureus and Clostridium difficile in patients with a documented penicillin allergy: population based matched cohort study. BMJ 361:k2400

  9. Picard M, Bégin P, Bouchard H, Cloutier J, Lacombe-Barrios J, Paradis J, Des Roches A, Laufer B, Paradis L (2013) Treatment of patients with a history of penicillin allergy in a large tertiary-care academic hospital. J Allergy Clin Immunol Pract 1(3):252–7

  10. Blumenthal KG, Ryan EE, Li Y, Lee H, Kuhlen JL, Shenoy ES (2018) The impact of a reported penicillin allergy on surgical site infection risk. Clin Infect Dis 66(3):329–336

    Article  PubMed  Google Scholar 

  11. Lee CE, Zembower TR, Fotis MA, Postelnick MJ, Greenberger PA, Peterson LR, Noskin GA (2000) The incidence of antimicrobial allergies in hospitalized patients: implications regarding prescribing patterns and emerging bacterial resistance. Arch Intern Med 160(18):2819–2822

    Article  CAS  PubMed  Google Scholar 

  12. MacLaughlin EJ, Saseen JJ, Malone DC (2000) Costs of beta-lactam allergies: selection and costs of antibiotics for patients with a reported beta-lactam allergy. Arch Fam Med 9(8):722–726

    Article  CAS  PubMed  Google Scholar 

  13. Sade K, Holtzer I, Levo Y, Kivity S (2003) The economic burden of antibiotic treatment of penicillin-allergic patients in internal medicine wards of a general tertiary care hospital. Clin Exp Allergy 33(4):501–506

    Article  CAS  PubMed  Google Scholar 

  14. MacFadden DR, LaDelfa A, Leen J, Gold WL, Daneman N, Weber E, Al-Busaidi I, Petrescu D, Saltzman I, Devlin M, Andany N, Leis JA. Impact of reported beta-lactam allergy on inpatient outcomes: a multicenter prospective cohort study

  15. American Academy of Allergy, Asthma & Immunology Choosing Wisely: ten things physicians and patients should question. Available at: https://www.choosingwisely.org/clinician-lists/american-academy-allergy-asthma-immunlogy-non-beta-lactam-antibiotics-penicillin-allergy/. Accessed 26 July, 2021

  16. Barlam TF, Cosgrove SE, Abbo LM, MacDougall C, Schuetz AN, Septimus EJ, Srinivasan A, Dellit TH, Falck-Ytter YT, Fishman NO, Hamilton CW, Jenkins TC, Lipsett PA, Malani PN, May LS, Moran GJ, Neuhauser MM, Newland JG, Ohl CA, Samore MH, Seo SK, Trivedi KK (2016) Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clin Infect Dis 62(10):e51-77

    Article  PubMed  PubMed Central  Google Scholar 

  17. Evaluation and diagnosis of penicillin allergy for healthcare professionals. Available at: https://www.cdc.gov/antibiotic-use/community/for-hcp/Penicillin-Allergy.html. Accessed 26 July, 2021

  18. Prevention of group B streptococcal early-onset disease in newborns: ACOG Committee Opinion (2020) Number 797. Obstet Gynecol 135(2):e51-e72

  19. Tucker MH, Lomas CM, Ramchandar N, Waldram JD (2017) Amoxicillin challenge without penicillin skin testing in evaluation of penicillin allergy in a cohort of marine recruits. J Allergy Clin Immunol Pract 5(3):813–815

  20. Kotas RV, Wells TJ, Mims LC, Trainor EJ, Wiles CL (1975) A new model for neonatal pulmonary hemorrhage research. Pediatr Res 9(4):161–165

    Article  CAS  PubMed  Google Scholar 

  21. Iammatteo M, Alvarez Arango S, Ferastraoaru D, Akbar N, Lee AY, Cohen HW, Jerschow E (2019) Safety and outcomes of oral graded challenges to amoxicillin without prior skin testing. J Allergy Clin Immunol Pract 7(1):236–243

    Article  PubMed  Google Scholar 

  22. Blumenthal KG, Huebner EM, Fu X, Li Y, Bhattacharya G, Levin AS, Mancini CM, Slawski BR, Banerji A (2019) Risk-based pathway for outpatient penicillin allergy evaluations. J Allergy Clin Immunol Pract 7(7):2411–2414.e1

  23. Ramsey A, Mustafa SS, Holly AM, Staicu ML (2020) Direct challenges to penicillin-based antibiotics in the inpatient setting. J Allergy Clin Immunol Pract 8(7):2294–2301

  24. Stevenson B, Trevenen M, Klinken E, Smith W, Yuson C, Katelaris C, Perram F, Burton P, Yun J, Cai F, Barnes S, Spriggs K, Ojaimi S, Mullins R, Salman S, Martinez P, Murray K, Lucas M (2020) Multicenter Australian study to determine criteria for low- and high-risk penicillin testing in outpatients. J Allergy Clin Immunol Pract 8(2):681-689.e3

    Article  PubMed  Google Scholar 

  25. Mill C, Primeau MN, Medoff E, Lejtenyi C, O'Keefe A, Netchiporouk E, Dery A, Ben-Shoshan M (2016) Assessing the diagnostic properties of a graded oral provocation challenge for the diagnosis of immediate and nonimmediate reactions to amoxicillin in children. JAMA Pediatr 170(6):e160033

  26. Allen HI, Vazquez-Ortiz M, Murphy AW, Moylett EM (2020) De-labeling penicillin-allergic children in outpatients using telemedicine: potential to replicate in primary care. J Allergy Clin Immunol Pract 8(5):1750–1752

    Article  PubMed  Google Scholar 

  27. Vyles D, Chiu A, Routes J, Castells M, Phillips EJ, Visotcky A, Fraser R, Pezzin L, Brousseau DC (2020) Oral amoxicillin challenges in low-risk children during a pediatric emergency department visit. J Allergy Clin Immunol Pract 8(3):1126-1128.e1

    Article  PubMed  Google Scholar 

  28. Zhang BY, Paquette V, McClymont E, Barlas A, Wong T, Watt M, Mak R, Elwood C (2021) Implementing a penicillin allergy delabeling service for the obstetric population. J Allergy Clin Immunol Pract 9(6):2501-2502.e2

    Article  PubMed  Google Scholar 

  29. Trubiano JA, Smibert O, Douglas A, Devchand M, Lambros B, Holmes NE, Chua KY, Phillips EJ, Slavin MA (2018) The safety and efficacy of an oral penicillin challenge program in cancer patients: a multicenter pilot study. Open Forum Infect Dis 5(12):ofy306

  30. Trubiano JA, Vogrin S, Chua KYL, Bourke J, Yun J, Douglas A, Stone CA, Yu R, Groenendijk L, Holmes NE, Phillips EJ (2020) Development and validation of a penicillin allergy clinical decision rule. JAMA Intern Med 180(5):745–752

    Article  PubMed  Google Scholar 

  31. Joint Task Force on Practice Parameters (2010) American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. Drug allergy: an updated practice parameter. Ann Allergy Asthma Immunol 105(4):259–273

  32. Solensky R, Jacobs J, Lester M, Lieberman P, McCafferty F, Nilsson T, Park M, Schwarz G, Soong W, Wagelie-Steffen A, Wedner HJ, Weiss M, Windom H, Tonascia J, Yates KP, Mendelson LM, Wolfe J, Adkinson NF (2019) Penicillin allergy evaluation: a prospective, multicenter, open-label evaluation of a comprehensive penicillin skin test kit. J Allergy Clin Immunol Pract 7(6):1876–1885.e3

  33. Devchand M, Urbancic KF, Khumra S, Douglas AP, Smibert O, Cohen E, Sutherland M, Phillips EJ, Trubiano JA (2019) Pathways to improved antibiotic allergy and antimicrobial stewardship practice: the validation of a beta-lactam antibiotic allergy assessment tool. J Allergy Clin Immunol Pract 7(3):1063-1065.e5

    Article  PubMed  Google Scholar 

  34. Chua KYL, Vogrin S, Bury S, Douglas A, Holmes NE, Tan N, Brusco NK, Hall R, Lambros B, Lean J, Stevenson W, Devchand M, Garrett K, Thursky K, Grayson ML, Slavin MA, Phillips EJ, Trubiano JA (2020) The penicillin allergy delabeling program: a multicenter whole-of-hospital health services intervention and comparative effectiveness study. Clin Infect Dis. ciaa653

  35. Khan DA, Banerji A, Bernstein JA, Bilgicer B, Blumenthal K, Castells M, Ein D, Lang DM, Phillips E (2019) Cephalosporin allergy: current understanding and future challenges. J Allergy Clin Immunol Pract 7(7):2105–2114

  36. Romano A, Valluzzi RL, Caruso C, Maggioletti M, Quaratino D, Gaeta F (2018) Cross-reactivity and tolerability of cephalosporins in patients with IgE-mediated hypersensitivity to penicillins. J Allergy Clin Immunol Pract 6(5):1662–1672

  37. Romano A, Valluzzi RL, Caruso C, Zaffiro A, Quaratino D, Gaeta F (2020) Tolerability of cefazolin and ceftibuten in patients with IgE-mediated aminopenicillin allergy. J Allergy Clin Immunol Pract 8(6):1989-1993.e2

    Article  PubMed  Google Scholar 

  38. Anstey KM, Anstey JE, Doernberg SB, Chen LL, Otani IM (2021) Perioperative use and safety of cephalosporin antibiotics in patients with documented penicillin allergy. J Allergy Clin Immunol Pract S2213–2198(21):00323–00328

    Google Scholar 

  39. Blumenthal KG, Shenoy ES, Varughese CA, Hurwitz S, Hooper DC, Banerji A (2015) Impact of a clinical guideline for prescribing antibiotics to inpatients reporting penicillin or cephalosporin allergy. Ann Allergy Asthma Immunol 115(4):294-300.e2

    Article  PubMed  PubMed Central  Google Scholar 

  40. Blumenthal KG, Shenoy ES, Wolfson AR, Berkowitz DN, Carballo VA, Balekian DS, Marquis KA, Elshaboury R, Gandhi RG, Meka P, Kubiak DW, Catella J, Lambl BB, Hsu JT, Freeley MM, Gruszecki A, Wickner PG (2017) Addressing inpatient beta-lactam allergies: a multihospital implementation. J Allergy Clin Immunol Pract 5(3):616–625.e7

  41. King EA, Challa S, Curtin P, Bielory L (2016) Penicillin skin testing in hospitalized patients with β-lactam allergies: effect on antibiotic selection and cost. Ann Allergy Asthma Immunol 117(1):67–71

    Article  CAS  PubMed  Google Scholar 

  42. Estep PM, Ferreira JA, Dupree LH, Aldridge PJ, Jankowski CA (2016) Impact of an antimicrobial stewardship initiative to evaluate β-lactam allergy in patients ordered aztreonam. Am J Health Syst Pharm 73(5 Suppl 1):S8-13

    Article  PubMed  Google Scholar 

  43. Chen JR, Tarver SA, Alvarez KS, Tran T, Khan DA (2017) A proactive approach to penicillin allergy testing in hospitalized patients. J Allergy Clin Immunol Pract. 5(3):686–693. https://doi.org/10.1016/j.jaip.2016.09.045

  44. Heil EL, Bork JT, Schmalzle SA, Kleinberg M, Kewalramani A, Gilliam BL, Buchwald UK (2016) Implementation of an infectious disease fellow-managed penicillin allergy skin testing service. Open Forum Infect Dis 3(3):ofw155

  45. Sigona NS, Steele JM, Miller CD (2016) Impact of a pharmacist-driven beta-lactam allergy interview on inpatient antimicrobial therapy: a pilot project. J Am Pharm Assoc (2003) 56(6):665–669

  46. Staicu ML, Brundige ML, Ramsey A, Brown J, Yamshchikov A, Peterson DR, Baran A, Laguio-Vila M (2016) Implementation of a penicillin allergy screening tool to optimize aztreonam use. Am J Health Syst Pharm 73(5):298–306

    Article  CAS  PubMed  Google Scholar 

  47. Swearingen SM, White C, Weidert S, Hinds M, Narro JP, Guarascio AJ (2016) A multidimensional antimicrobial stewardship intervention targeting aztreonam use in patients with a reported penicillin allergy. Int J Clin Pharm 38(2):213–217

    Article  CAS  PubMed  Google Scholar 

  48. Blumenthal KG, Wickner PG, Hurwitz S, Pricco N, Nee AE, Laskowski K, Shenoy ES, Walensky RP (2017) Tackling inpatient penicillin allergies: assessing tools for antimicrobial stewardship. J Allergy Clin Immunol 140(1):154-161.e6

    Article  PubMed  PubMed Central  Google Scholar 

  49. Ramsey A, Staicu ML (2018) Use of a penicillin allergy screening algorithm and penicillin skin testing for transitioning hospitalized patients to first-line antibiotic therapy. J Allergy Clin Immunol Pract 6(4):1349–1355

  50. Devchand M, Kirkpatrick CMJ, Stevenson W, Garrett K, Perera D, Khumra S, Urbancic K, Grayson ML, Trubiano JA (2019) Evaluation of a pharmacist-led penicillin allergy de-labelling ward round: a novel antimicrobial stewardship intervention. J Antimicrob Chemother 74(6):1725–1730

    Article  CAS  PubMed  Google Scholar 

  51. du Plessis T, Walls G, Jordan A, Holland DJ (2019) Implementation of a pharmacist-led penicillin allergy de-labelling service in a public hospital. J Antimicrob Chemother 74(5):1438–1446

    Article  PubMed  CAS  Google Scholar 

  52. Harmon S, Richardson T, Simons H, Monforte S, Fanning S, Harrington K (2020) The clinical and financial impact of a pharmacist-driven penicillin skin testing program on antimicrobial stewardship practices. Hosp Pharm 55(1):58–63

    Article  PubMed  Google Scholar 

  53. Blumenthal KG, Li Y, Hsu JT, Wolfson AR, Berkowitz DN, Carballo VA, Schwartz JM, Marquis KA, Elshaboury R, Gandhi RG, Lambl BB, Freeley MM, Gruszecki A, Wickner PG, Shenoy ES (2019) Outcomes from an inpatient beta-lactam allergy guideline across a large US health system. Infect Control Hosp Epidemiol 40(5):528–535

    Article  PubMed  PubMed Central  Google Scholar 

  54. Sacco KA, Cochran BP, Epps K, Parkulo M, Gonzalez-Estrada A (2019) Inpatient β-lactam test-dose protocol and antimicrobial stewardship in patients with a history of penicillin allergy. Ann Allergy Asthma Immunol 122(2):184–188

    Article  CAS  PubMed  Google Scholar 

  55. Wall GC, Peters L, Leaders CB, Wille JA (2004) Pharmacist-managed service providing penicillin allergy skin tests. Am J Health Syst Pharm 61(12):1271–1275

    Article  PubMed  Google Scholar 

  56. Lucas M, Arnold A, Sommerfield A, Trevenen M, Braconnier L, Schilling A, Abass F, Slevin L, Knezevic B, Blyth C, Murray K, von Ungern-Sternberg B, Rueter K (2019) Antibiotic allergy labels in children are associated with adverse clinical outcomes. J Allergy Clin Immunol Pract 7(3):975–982

    Article  PubMed  Google Scholar 

  57. Ibia EO, Schwartz RH, Wiedermann BL (2000) Antibiotic rashes in children: a survey in a private practice setting. Arch Dermatol 136(7):849–854

    Article  CAS  PubMed  Google Scholar 

  58. Blanca-López N, Zapatero L, Alonso E, Torres MJ, Fuentes V, Martínez-Molero MI, Blanca M (2009) Skin testing and drug provocation in the diagnosis of nonimmediate reactions to aminopenicillins in children. Allergy 64(2):229–233

    Article  PubMed  CAS  Google Scholar 

  59. Zambonino MA, Corzo JL, Muñoz C, Requena G, Ariza A, Mayorga C, Urda A, Blanca M, Torres MJ (2014) Diagnostic evaluation of hypersensitivity reactions to beta-lactam antibiotics in a large population of children. Pediatr Allergy Immunol 25(1):80–87

    Article  PubMed  Google Scholar 

  60. Caubet JC, Frossard C, Fellay B, Eigenmann PA (2015) Skin tests and in vitro allergy tests have a poor diagnostic value for benign skin rashes due to β-lactams in children. Pediatr Allergy Immunol 26(1):80–82

    Article  PubMed  Google Scholar 

  61. Confino-Cohen R, Rosman Y, Meir-Shafrir K, Stauber T, Lachover-Roth I, Hershko A, Goldberg A (2017) Oral challenge without skin testing safely excludes clinically significant delayed-onset penicillin hypersensitivity. J Allergy Clin Immunol Pract 5(3):669–675

  62. Staicu ML, Holly AM, Conn KM, Ramsey A (2018) The use of telemedicine for penicillin allergy skin testing. J Allergy Clin Immunol Pract 6(6):2033–2040

  63. Wolfson AR, Mancini CM, Banerji A, Fu X, Bryant AS, Phadke NA, Shenoy ES, Arman W, Zhang Y, Blumenthal KG (2021) Penicillin allergy assessment in pregnancy: safety and impact on antibiotic use. J Allergy Clin Immunol Pract 9(3):1338–1346

    Article  PubMed  Google Scholar 

  64. Blumenthal KG, Shenoy ES, Hurwitz S, Varughese CA, Hooper DC, Banerji A (2014) Effect of a drug allergy educational program and antibiotic prescribing guideline on inpatient clinical providers’ antibiotic prescribing knowledge. J Allergy Clin Immunol Pract 2(4):407–13

  65. Stukus DR, Green T, Montandon SV, Wada KJ (2015) Deficits in allergy knowledge among physicians at academic medical centers. Ann Allergy Asthma Immunol 115(1):51-55.e1

    Article  PubMed  Google Scholar 

  66. Lutfeali S, DiLoreto FF, Alvarez KS, Patel SV, Joshi SR, Tarver SA, Khan DA (2021) Maintaining penicillin allergy delabeling: a quality improvement initiative. J Allergy Clin Immunol Pract 9(5):2104-2106.e2

    Article  PubMed  Google Scholar 

  67. Lachover-Roth I, Sharon S, Rosman Y, Meir-Shafrir K, Confino-Cohen R (2019) Long-term follow-up after penicillin allergy delabeling in ambulatory patients. J Allergy Clin Immunol Pract 7(1):231-235.e1

    Article  PubMed  Google Scholar 

  68. Warrington RJ, Lee KR, McPhillips S (2000) The value of skin testing for penicillin allergy in an inpatient population: analysis of the subsequent patient management. Allergy Asthma Proc 21(5):297–9

  69. Gerace KS, Phillips E (2015) Penicillin allergy label persists despite negative testing. J Allergy Clin Immunol Pract 3(5):815–6

  70. Rimawi RH, Shah KB, Cook PP (2013) Risk of redocumenting penicillin allergy in a cohort of patients with negative penicillin skin tests. J Hosp Med 8(11):615–8

  71. Moussa Y, Sullivan A, Matte G, Goldstein RH, Baldini G, Shuster J, Tsoukas C (2020) Impact of persistent β-lactam allergy documentation despite delabeling in the perioperative setting. J Allergy Clin Immunol Pract 8(1):411–412

    Article  PubMed  Google Scholar 

  72. Savic L, Thomas C, Fallaha D, Wilson M, Hopkins PM, Savic S, Clark SH (2020) RAFT group. DALES, Drug Allergy Labels in Elective Surgical patients: a prospective multicentre cross-sectional study of incidence, risks, and attitudes in penicillin de-labelling strategies. Br J Anaesth 125(6):962–969

  73. Taremi M, Artau A, Foolad F, Berlin S, White C, Jiang Y, Raad I, Adachi J (2019) Safety, efficacy, and clinical impact of penicillin skin testing in immunocompromised cancer patients. J Allergy Clin Immunol Pract 7(7):2185–2191.e1

  74. Desravines N, Waldron J, Venkatesh KK, Kwan M, Boggess KA (2021) Outpatient penicillin allergy testing in pregnant women who report an allergy. Obstet Gynecol 137(1):56–61

    Article  CAS  PubMed  Google Scholar 

  75. Anstey KM, Choi L, Dawson D, Kleinhenz ME, Otani IM (2021) Enabling antibiotic allergy evaluations and reintroduction of first-line antibiotics for patients with cystic fibrosis. Ann Allergy Asthma Immunol S1081–1206(21):00412–00419

    Google Scholar 

  76. Petroni DH, Aitken ML, Ham E, Chung S, Menalia L, Altman MC, Ayars AG (2016) Approach to the evaluation of adverse antibiotic reactions in patients with cystic fibrosis. Ann Allergy Asthma Immunol 117(4):378–381

    Article  CAS  PubMed  Google Scholar 

  77. Brown M, Uzoma J, Vansice R, Mahan K, Conn KM, Ramsey A, Staicu ML (2021) Examining the impact of a penicillin allergy skin testing brochure on inpatient perceptions: a pre-post intervention study. J Allergy Clin Immunol Pract 9(4):1736-1737.e3

    Article  PubMed  Google Scholar 

  78. Bratzler DW, Dellinger EP, Olsen KM, Perl TM, Auwaerter PG, Bolon MK, Fish DN, Napolitano LM, Sawyer RG, Slain D, Steinberg JP, Weinstein RA (2013) American Society of Health-System Pharmacists; Infectious Disease Society of America; Surgical Infection Society; Society for Healthcare Epidemiology of America. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm 70(3):195–283

  79. Cook DJ, Barbara DW, Singh KE, Dearani JA (2014) Penicillin skin testing in cardiac surgery. J Thorac Cardiovasc Surg 147(6):1931–1935

    Article  PubMed  Google Scholar 

  80. Plager JH, Mancini CM, Fu X, Melnitchouk S, Shenoy ES, Banerji A, Collier L, Chaudhary N, Yerneni S, Zhang Y, Blumenthal KG (2020) Preoperative penicillin allergy testing in patients undergoing cardiac surgery. Ann Allergy Asthma Immunol 124(6):583–588

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Li JT, Markus PJ, Osmon DR, Estes L, Gosselin VA, Hanssen AD (2000) Reduction of vancomycin use in orthopedic patients with a history of antibiotic allergy. Mayo Clin Proc 75(9):902–906

    Article  CAS  PubMed  Google Scholar 

  82. Frigas E, Park MA, Narr BJ, Volcheck GW, Danielson DR, Markus PJ, Olson KE, Schroeder DR, Kita H (2008) Preoperative evaluation of patients with history of allergy to penicillin: comparison of 2 models of practice. Mayo Clin Proc 83(6):651–662

    Article  PubMed  Google Scholar 

  83. Park M, Markus P, Matesic D, Li JT (2006) Safety and effectiveness of a preoperative allergy clinic in decreasing vancomycin use in patients with a history of penicillin allergy. Ann Allergy Asthma Immunol 97(5):681–687

    Article  CAS  PubMed  Google Scholar 

  84. Moussa Y, Shuster J, Matte G, Sullivan A, Goldstein RH, Cunningham D, Ben-Shoshan M, Baldini G, Carli F, Tsoukas C (2018) De-labeling of β-lactam allergy reduces intraoperative time and optimizes choice in antibiotic prophylaxis. Surgery S0039–6060(18):30127–30132

    Google Scholar 

  85. Pagani NR, Moverman MA, Puzzitiello RN, Menendez ME, Barnes CL, Kavolus JJ (2021) Preoperative allergy testing for patients reporting penicillin and cephalosporin allergies is cost-effective in preventing infection after total knee and hip arthroplasty. J Arthroplasty 36(2):700–704

    Article  PubMed  Google Scholar 

  86. Beltran RJ, Kako H, Chovanec T, Ramesh A, Bissonnette B, Tobias JD (2015) Penicillin allergy and surgical prophylaxis: cephalosporin cross-reactivity risk in a pediatric tertiary care center. J Pediatr Surg 50(5):856–859

    Article  PubMed  Google Scholar 

  87. Kuruvilla M, Sexton M, Wiley Z, Langfitt T, Lynde GC, Wolf F (2020) A streamlined approach to optimize perioperative antibiotic prophylaxis in the setting of penicillin allergy labels. J Allergy Clin Immunol Pract 8(4):1316–1322

    Article  PubMed  Google Scholar 

  88. Vaisman A, McCready J, Hicks S, Powis J (2017) Optimizing preoperative prophylaxis in patients with reported β-lactam allergy: a novel extension of antimicrobial stewardship. J Antimicrob Chemother 72(9):2657–2660

    Article  CAS  PubMed  Google Scholar 

  89. Cook E, Ramirez M, Turrentine M (2020) Time has come for routine penicillin allergy testing in obstetrics. AJP Rep 10(1):e15–e19

    Article  PubMed  PubMed Central  Google Scholar 

  90. Desai SH, Kaplan MS, Chen Q, Macy EM (2017) Morbidity in pregnant women associated with unverified penicillin allergies, antibiotic use, and group B Streptococcus infections. Perm J 21:16–080

    Article  PubMed  PubMed Central  Google Scholar 

  91. Fairlie T, Zell ER, Schrag S (2013) Effectiveness of intrapartum antibiotic prophylaxis for prevention of early-onset group B streptococcal disease. Obstet Gynecol 121(3):570–577

    Article  CAS  PubMed  Google Scholar 

  92. Committee on Practice Bulletins-Obstetrics (2018) ACOG Practice Bulletin No. 199: use of prophylactic antibiotics in labor and delivery. Obstet Gynecol 132(3):e103-e119

  93. Siegel AM, Heine RP, Dotters-Katz SK (2019) The effect of non-penicillin antibiotic regimens on neonatal outcomes in preterm premature rupture of membranes. AJP Rep 9(1):e67–e71

    Article  PubMed  PubMed Central  Google Scholar 

  94. Harris BS, Hopkins MK, Villers MS, Weber JM, Pieper C, Grotegut CA, Swamy GK, Hughes BL, Heine RP (2019) Efficacy of non-beta-lactam antibiotics for prevention of cesarean delivery surgical site infections. AJP Rep 9(2):e167–e171

    Article  PubMed  PubMed Central  Google Scholar 

  95. Hopkins MK, Dotters-Katz S, Boggess K, Heine RP, Smid M (2018) Perioperative antibiotic choice in labored versus unlabored cesareans and risk of postcesarean infectious morbidity. Am J Perinatol 35(2):127–133

    Article  PubMed  Google Scholar 

  96. Regan JA, Klebanoff MA, Nugent RP (1991) The epidemiology of group B streptococcal colonization in pregnancy. Vaginal Infections and Prematurity Study Group. Obstet Gynecol 77(4):604–10

  97. Campbell JR, Hillier SL, Krohn MA, Ferrieri P, Zaleznik DF, Baker CJ (2000) Group B streptococcal colonization and serotype-specific immunity in pregnant women at delivery. Obstet Gynecol 96(4):498–503

    CAS  PubMed  Google Scholar 

  98. Sakai-Bizmark R, Ross MG, Estevez D, Bedel LEM, Marr EH, Tsugawa Y (2021) Evaluation of hospital cesarean delivery-related profits and rates in the United States. JAMA Netw Open 4(3):e212235

  99. Goldenberg RL, Culhane JF, Iams JD, Romero R (2008) Epidemiology and causes of preterm birth. Lancet 371(9606):75–84. https://doi.org/10.1016/S0140-6736(08)60074-4

    Article  PubMed  PubMed Central  Google Scholar 

  100. Foxman B, D’Arcy H, Gillespie B, Bobo JK, Schwartz K (2002) Lactation mastitis: occurrence and medical management among 946 breastfeeding women in the United States. Am J Epidemiol 155(2):103–114

    Article  PubMed  Google Scholar 

  101. Pustotina O (2016) Management of mastitis and breast engorgement in breastfeeding women. J Matern Fetal Neonatal Med 29(19):3121–3125

    Article  PubMed  Google Scholar 

  102. Macy E (2006) Penicillin skin testing in pregnant women with a history of penicillin allergy and group B streptococcus colonization. Ann Allergy Asthma Immunol 97(2):164–168

    Article  PubMed  Google Scholar 

  103. Philipson EH, Lang DM, Gordon SJ, Burlingame JM, Emery SP, Arroliga ME (2007) Management of group B Streptococcus in pregnant women with penicillin allergy. J Reprod Med 52(6):480–484

    PubMed  Google Scholar 

  104. Kuder MM, Lennox MG, Li M, Lang DM, Pien L (2020) Skin testing and oral amoxicillin challenge in the outpatient allergy and clinical immunology clinic in pregnant women with penicillin allergy. Ann Allergy Asthma Immunol 125(6):646–651

    Article  CAS  PubMed  Google Scholar 

  105. Trubiano JA, Slavin MA, Thursky KA, Grayson ML, Phillips EJ (2019) Beta-lactam and sulfonamide allergy testing should be a standard of care in immunocompromised hosts. J Allergy Clin Immunol Pract 7(7):2151–2153

  106. Anstey KM, Lee M, Dawson D, Jue V, Budzik JM, Yu M, Kleinhenz ME, Otani IM (2020) Antibiotic adverse reactions in adult cystic fibrosis patients. J Allergy Clin Immunol Pract 8(10):3631–3633.e1

  107. Chow TG, Khan DA (2021) Sulfonamide hypersensitivity. Clin Rev Allergy Immunol. https://doi.org/10.1007/s12016-021-08872-3

    Article  PubMed  Google Scholar 

  108. CF Foundation Patient Registry, Annual Data Report 2017. Available at: https://www.cff.org/Research/Researcher-Resources/Patient-Registry/2017-Patient-Registry-Annual-Data-Report.pdf. Accessed 17 April, 2020

  109. Braun C, Reix P, Durieu I, Nove-Josserand R, Durupt S, Ohlmann C, Mainguy C, Nicolas JF, Nosbaum A, Jubin V (2020) The diagnosis of hypersensitivity to antibiotics is rarely confirmed by allergy work-up in cystic fibrosis patients. Pediatr Allergy Immunol 31(4):396–404

    Article  PubMed  Google Scholar 

  110. Williams AM, Baran AM, Meacham PJ, Feldman MM, Valencia HE, Newsom-Stewart C, Gupta N, Janelsins MC, Barr PM, Zent CS (2018) Analysis of the risk of infection in patients with chronic lymphocytic leukemia in the era of novel therapies. Leuk Lymphoma 59(3):625–632

    Article  PubMed  Google Scholar 

  111. Casazza AR, Duvall CP, Carbone PP (1966) Infection in lymphoma. Histology, treatment, and duration in relation to incidence and survival. JAMA 197(9):710–6

  112. Blimark C, Holmberg E, Mellqvist UH, Landgren O, Björkholm M, Hultcrantz M, Kjellander C, Turesson I, Kristinsson SY (2015) Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients. Haematologica 100(1):107–113

    Article  PubMed  PubMed Central  Google Scholar 

  113. Safdar A, Armstrong D (2011) Infections in patients with hematologic neoplasms and hematopoietic stem cell transplantation: neutropenia, humoral, and splenic defects. Clin Infect Dis 53(8):798–806

    Article  PubMed  Google Scholar 

  114. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JA, Wingard JR (2011) Infectious Diseases Society of America. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 52(4):e56–93

  115. Taplitz RA, Kennedy EB, Bow EJ, Crews J, Gleason C, Hawley DK, Langston AA, Nastoupil LJ, Rajotte M, Rolston K, Strasfeld L, Flowers CR (2018) Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update. J Clin Oncol 36(14):1443–1453

    Article  PubMed  Google Scholar 

  116. Huang KG, Cluzet V, Hamilton K, Fadugba O (2018) The impact of reported beta-lactam allergy in hospitalized patients with hematologic malignancies requiring antibiotics. Clin Infect Dis 67(1):27–33

    Article  PubMed  Google Scholar 

  117. Modi AR, Majhail NS, Rybicki L, Athans V, Carlstrom K, Srinivas P, Lang DM, Sobecks R, Kovacs CS (2019) Penicillin allergy skin testing as an antibiotic stewardship intervention reduces alternative antibiotic exposures in hematopoietic stem cell transplant recipients. Transpl Infect Dis 21(6):e13175

  118. Imlay H, Krantz EM, Stohs EJ, Lan KF, Zier J, Kim HN, Rakita RM, Limaye AP, Wald A, Pergam SA, Liu C (2020) Reported β-lactam and other antibiotic allergies in solid organ and hematopoietic cell transplant recipients. Clin Infect Dis 71(7):1587–1594

    Article  CAS  PubMed  Google Scholar 

  119. Khumra S, Chan J, Urbancic K, Worland T, Angus P, Jones R, Grayson ML, Trubiano JA (2017) Antibiotic allergy labels in a liver transplant recipient study. Antimicrob Agents Chemother 61(5):e00078-e117

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  120. Padmanabhan Menon D, Sacco K, Shalev JA, Narula T, Gonzalez-Estrada A (2019) Safety of penicillin allergy skin testing in patients with low lung volumes before lung transplant. Ann Allergy Asthma Immunol 122(1):122–123

    Article  PubMed  Google Scholar 

  121. Gutta R, Radojicic C (2012) Safety and effectiveness of penicillin allergy evaluation in the pre-lung transplant patient population. J Allergy Clin Immunol 129(2):S1A-4A

    Article  Google Scholar 

  122. Petri M, Genovese M (1992) Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: a prospective study of the Hopkins Lupus Cohort. J Rheumatol 19(10):1559–1565

    CAS  PubMed  Google Scholar 

  123. von Maur K, Turk A, Stevens MB, Adkinson NF Jr, Lichtenstein LM (1975) Penicillin hypersensitivity in systemic lupus erythematosus. Int Arch Allergy Appl Immunol 49(4):428–433

    Article  Google Scholar 

  124. Petri M, Allbritton J (1992) Antibiotic allergy in systemic lupus erythematosus: a case-control study. J Rheumatol 19(2):265–269

    CAS  PubMed  Google Scholar 

  125. Mortezavi M, Mustafa SS, Ramsey A (2020) Penicillin skin testing immunocompromised patients with systemic lupus erythematosus and rheumatoid arthritis. Ann Allergy Asthma Immunol 124(3):298–299

    Article  PubMed  Google Scholar 

  126. UCSF Inpatient Beta-lactam Allergy Guideline. Available at: https://idmp.ucsf.edu/content/inpatient-beta-lactam-allergy-guideline. Accessed 26 July, 2021

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Karen M. Anstey.

Ethics declarations

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Anstey, K.M., Tsao, L. & Otani, I.M. Drug Allergy Delabeling Programs: Recent Strategies and Targeted Populations. Clinic Rev Allerg Immunol 62, 484–504 (2022). https://doi.org/10.1007/s12016-021-08913-x

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12016-021-08913-x

Keywords

Navigation